Monday, April 17, 2017
Havana.- Cuban specialists exchanged experiences on the use of Hebervital, a product developed by the Center for Genetic Engineering and Biotechnology.
The mentioned formulation was used with notable benefits in different pathological processes registered in the Cuban health system.
Hematologists, oncologists, orthopedists, dentists, intensivists and other branches of medicine evaluated the benefits of the product and new clinical research in the field.
Hebervital is specified for patients receiving chemotherapy, radiation therapy, bone marrow transplants and immunosuppressed persons, experts say.
It also applies to patients with decreased body defenses and a history of severe or recurrent infections, and among its benefits reduces the use of antibiotics and the frequency of hospitalization.